Bruno Coutard

InstitutionUnité des Virus Émergents (UVE: Aix-Marseille Univ - IRD 190 - Inserm 1207 - IHU Méditerranée Infection)
AddressMarseille
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in August 2020 and March 2021
    All Publications
    Bar chart showing 76 publications over 18 distinct years, with a maximum of 8 publications in 2006
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Driouich JS, Cochin M, Lingas G, Moureau G, Touret F, Petit PR, Piorkowski G, Barthélémy K, Laprie C, Coutard B, Guedj J, de Lamballerie X, Solas C, Nougairède A. Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nat Commun. 2021 03 19; 12(1):1735. PMID: 33741945.
      Citations: 22     Fields:    Translation:AnimalsCells
    2. Abuduaini T, Roy V, Marlet J, Gaudy-Graffin C, Brand D, Baronti C, Touret F, Coutard B, McBrayer TR, Schinazi RF, Agrofoglio LA. Synthesis and Antiviral Evaluation of (1,4-Disubstituted-1,2,3-Triazol)-(E)-2-Methyl-but-2-Enyl Nucleoside Phosphonate Prodrugs. Molecules. 2021 Mar 09; 26(5). PMID: 33803417.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    3. Coutard B, Romette JL, Miyauchi K, Charrel R, Prat CMA. The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 Crisis. Biopreserv Biobank. 2020 Dec; 18(6):561-569. PMID: 33181021.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    4. Shannon A, Selisko B, Le NT, Huchting J, Touret F, Piorkowski G, Fattorini V, Ferron F, Decroly E, Meier C, Coutard B, Peersen O, Canard B. Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis. Nat Commun. 2020 09 17; 11(1):4682. PMID: 32943628.
      Citations: 54     Fields:    Translation:AnimalsCellsPHPublic Health
    5. Valle C, Martin B, Touret F, Shannon A, Canard B, Guillemot JC, Coutard B, Decroly E. Drugs against SARS-CoV-2: What do we know about their mode of action? Rev Med Virol. 2020 11; 30(6):1-10. PMID: 32779326.
      Citations: 14     Fields:    Translation:Humans
    6. Touret F, Gilles M, Barral K, Nougairède A, van Helden J, Decroly E, de Lamballerie X, Coutard B. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci Rep. 2020 08 04; 10(1):13093. PMID: 32753646.
      Citations: 124     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    7. Pezzi L, Charrel RN, Ninove L, Nougairede A, Molle G, Coutard B, Durand G, Leparc-Goffart I, de Lamballerie X, Thirion L. Development and Evaluation of a duo SARS-CoV-2 RT-qPCR Assay Combining Two Assays Approved by the World Health Organization Targeting the Envelope and the RNA-Dependant RNA Polymerase (RdRp) Coding Regions. Viruses. 2020 06 25; 12(6). PMID: 32630601.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    8. Mögling R, Meijer A, Berginc N, Bruisten S, Charrel R, Coutard B, Eckerle I, Enouf V, Hungnes O, Korukluoglu G, Kossyvakis T, Mentis A, Molenkamp R, Muradrasoli S, Papa A, Pigny F, Thirion L, van der Werf S, Reusken C. Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination. Emerg Infect Dis. 2020 08; 26(8):1944-1946. PMID: 32433015.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    9. Coutard B, Coutard B, Valle C, de Lamballerie X, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020 04; 176:104742. PMID: 32057769.
      Citations: 607     Fields:    Translation:Cells